Received Aug 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | 2 | Z003767 | OT |
No additional AE reported; HCP called to report T/E. HCP stated VARIVAX was administered inadvertently during T/E. Permission was given to contact HCP for further information. T/E date was on 8/4/2025 , VARIVAX was administered on 8/7/2025. No additional information was provid; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 07-AUG-2025, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Z003767, expiration date: 30-Jan-2027), dose number 2, 0.5 mL, administered by unknown route as prophylaxis. The vaccine was administered after being improperly stored (temperature excursion took place on 04-AUG-2025); temperature: -8.5 C, time frame: 2 hour 34 minutes 0 seconds (Product storage error). No additional adverse event reported. The outcome of the event was unknown. The action taken with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) was not applicable.
Sterile diluent